Valsartan and Sweating increased - a phase IV clinical study of FDA data
Summary:
Sweating increased is reported as a side effect among people who take Valsartan (valsartan), especially for people who are female, 60+ old, also take Celebrex,.
The phase IV clinical study analyzes which people have Sweating increased when taking Valsartan. It is created by eHealthMe based on reports of 62,763 people who have side effects when taking Valsartan from the FDA, and is updated regularly.
What is Valsartan?
Valsartan has active ingredients of valsartan. It is often used in high blood pressure. eHealthMe is studying from 63,805 Valsartan users. Check the latest studies of Valsartan.
What is Sweating increased?
Sweating increased (excess sweating) is found to be associated with 678 drugs and 414 conditions by eHealthMe. Check the latest studies of Sweating increased.
62,763 people reported to have side effects when taking Valsartan.
Among them, 13 people (0.02%) have Sweating increased.

Among these 13 people:
What is the gender of people who have Sweating increased when taking Valsartan? *
- female: 53.85 %
- male: 46.15 %
What is the age of people who have Sweating increased when taking Valsartan? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 18.18 %
- 60+: 81.82 %
What are other drugs people take besides Valsartan? *
- Celebrex: 5 people, 38.46%
- Ipratropium Bromide: 3 people, 23.08%
- Folic Acid: 3 people, 23.08%
- Albuterol: 3 people, 23.08%
- Methotrexate: 3 people, 23.08%
- Hydrochlorothiazide: 3 people, 23.08%
- Hytrin: 3 people, 23.08%
- Misoprostol: 3 people, 23.08%
- Diclofenac Sodium: 3 people, 23.08%
- Cimetidine: 3 people, 23.08%
What are other side effects people have besides Sweating increased? *
- Weakness: 7 people, 53.85%
- Paleness (unusual lightness of skin colour): 4 people, 30.77%
- Hypotension (abnormally low blood pressure): 3 people, 23.08%
- Postural Hypotension: 3 people, 23.08%
- Heart Attack: 2 people, 15.38%
- Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 2 people, 15.38%
- Fainting (loss of consciousness and postural tone): 2 people, 15.38%
- Heart Rate Increased: 2 people, 15.38%
- Hypoaesthesia (reduced sense of touch or sensation): 2 people, 15.38%
- Chest Pressure Sensation (feeling of pressure on chest): 2 people, 15.38%
* Approximation only. Some reports may have incomplete information.
Do you take Valsartan and have Sweating increased?
- Check whether Sweating increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Valsartan:
- Valsartan (63,805 reports)
Sweating increased treatments and more:
- Sweating increased (12,830 reports)
How severe was Sweating increased and when was it recovered:
Expand to all the drugs that have ingredients of valsartan:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Valsartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Sweating increased:
- Sweating increased (678 drugs)
Browse all the conditions that are associated with Sweating increased:
- Sweating increased (414 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on valsartan (the active ingredients of Valsartan) and Valsartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Duloxetine Hydrochloride cause Lip Swelling? - 4 seconds ago
- Acute Myeloid Leukaemia and Nosebleed - 4 seconds ago
- Could Apixaban cause Arthritis? - 4 seconds ago
- Could Duloxetine Hydrochloride cause Gamma-Glutamyltransferase Increased? - 9 seconds ago
- Could Theo-Dur cause Thrombophlebitis? - 13 seconds ago
- Could Megace cause Paleness? - 21 seconds ago
- Drug interactions of Testosterone Cypionate and Spiriva - 23 seconds ago
- Could Humalog Pen cause Stroke? - 34 seconds ago
- Could Augmentin '125' cause Arteriovenous Fistula Site Complication? - 38 seconds ago
- Drug interactions of Probiotic and Vitamin D3 - 55 seconds ago